BioVaxys Technology Corp. (CSE:BIOV)
Canada · Delayed Price · Currency is CAD 0.0600
0.00 (0.00%)
Apr 29, 2026, 1:21 PM EST
BioVaxys Technology Market Cap
BioVaxys Technology has a market cap or net worth of CAD 2.65 million as of May 1, 2026. Its market cap has decreased by -84.87% in one year.
Market Cap
2.65M
Enterprise Value
2.78M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since October 6, 2020, BioVaxys Technology's market cap has decreased from 27.06M to 2.65M, a decrease of -90.22%. That is a compound annual growth rate of -34.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 2.65M | -72.73% |
| Dec 31, 2025 | 9.70M | -41.13% |
| Dec 31, 2024 | 16.48M | 127.10% |
| Dec 29, 2023 | 7.26M | -47.89% |
| Dec 30, 2022 | 13.92M | -26.37% |
| Dec 31, 2021 | 18.91M | 32.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptose Biosciences | 6.00M |
| Quest PharmaTech | 5.92M |
| MYND Life Sciences | 5.22M |
| Doseology Sciences | 4.97M |
| Restart Life Sciences | 4.75M |
| Cytophage Technologies | 4.40M |
| ASEP Medical Holdings | 3.45M |
| Appili Therapeutics | 2.65M |